BTG plc (LON:BTG – Get Free Report) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 840 ($11.08) and traded as high as GBX 840 ($11.08). BTG shares last traded at GBX 840 ($11.08), with a volume of 271,742 shares changing hands.
BTG Stock Performance
The company has a market cap of £3.26 billion and a P/E ratio of 29.47. The business’s fifty day moving average is GBX 840 and its two-hundred day moving average is GBX 840.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Stories
- Five stocks we like better than BTG
- What Are Dividend Champions? How to Invest in the Champions
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Brinker International Offers a Pullback Opportunity on EPS Miss
- About the Markup Calculator
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
